Word

NITYR

Status

Registered

Status Code

700

Status Date

Tuesday, April 2, 2019

Serial Number

87604011

Registration Number

5716643

Registration Date

Tuesday, April 2, 2019

Mark Type

4000

Filing Date

Monday, September 11, 2017

Published for Opposition

Tuesday, September 4, 2018

Trademark Owner History

Cycle Pharmaceuticals Ltd. - Original Registrant

Classifications

5 (Based on 44(e)) Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system, pharmaceutical agents for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system, pharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system, supplements for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system, biological preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system, chemical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of disorders of the metabolism and digestive system, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system, drugs for the treatment of rare diseases, in particular for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of disorders of the metabolism and digestive system, enzyme preparations for the treatment of tyrosinemia and hypertyrosinemia, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems, medical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches

35 (Based on 44(e)) Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; business information in the field of pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches

44 (Based on 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticals, medicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; dispensing of pharmaceuticals, medicines and supplements; dispensing of pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to tyrosinemia and hypertyrosinemia; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to tyrosinemia and hypertyrosinemia; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; medical, pharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medical, pharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medical, pharmacological and pharmaceutical testing services in relation to rare diseases; medical, pharmacological and pharmaceutical testing services in relation to tyrosinemia and hypertyrosinemia; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of tyrosinemia and hypertyrosinemia; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to tyrosinemia and hypertyrosinemia; providing news and information in the field of medicine; providing news and information in the field of rare diseases

Trademark Events

Apr 3, 2024

Teas Change Of Correspondence Received

Apr 3, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Apr 3, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 2, 2024

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Mar 15, 2022

Teas Change Of Correspondence Received

Mar 15, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 15, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Oct 28, 2020

Assignment Of Ownership Not Updated Automatically

May 20, 2019

Teas Change Of Correspondence Received

Apr 2, 2019

Registered-Principal Register

Feb 27, 2019

Notice Of Acceptance Of Statement Of Use E-Mailed

Feb 26, 2019

Allowed Principal Register - Sou Accepted

Feb 26, 2019

Teas/Email Correspondence Entered

Feb 26, 2019

Correspondence Received In Law Office

Feb 25, 2019

Teas Response To Office Action Received

Feb 15, 2019

Notification Of Non-Final Action E-Mailed

Feb 15, 2019

Non-Final Action E-Mailed

Feb 15, 2019

Su - Non-Final Action - Written

Feb 14, 2019

Statement Of Use Processing Complete

Jan 23, 2019

Use Amendment Filed

Feb 14, 2019

Case Assigned To Intent To Use Paralegal

Jan 23, 2019

Teas Statement Of Use Received

Jan 17, 2019

Corrected Noa E-Mailed

Oct 30, 2018

Noa E-Mailed - Sou Required From Applicant

Sep 4, 2018

Official Gazette Publication Confirmation E-Mailed

Sep 4, 2018

Published For Opposition

Aug 15, 2018

Notification Of Notice Of Publication E-Mailed

Aug 10, 2018

Assigned To Examiner

Aug 1, 2018

Electronic Record Review Complete

Jul 27, 2018

On Hold - Electronic Record Review Required

Jul 24, 2018

Electronic Record Review Complete

Jul 13, 2018

On Hold - Electronic Record Review Required

Jul 12, 2018

Electronic Record Review Complete

Jun 29, 2018

On Hold - Electronic Record Review Required

Jun 27, 2018

Approved For Pub - Principal Register

Jun 27, 2018

Examiner's Amendment Entered

Jun 27, 2018

Notification Of Examiners Amendment E-Mailed

Jun 27, 2018

Examiners Amendment E-Mailed

Jun 27, 2018

Examiners Amendment -Written

Jun 20, 2018

Teas/Email Correspondence Entered

Jun 20, 2018

Correspondence Received In Law Office

Jun 11, 2018

Teas Response To Office Action Received

May 1, 2018

Notification Of Non-Final Action E-Mailed

May 1, 2018

Non-Final Action E-Mailed

May 1, 2018

Non-Final Action Written

Apr 11, 2018

Teas/Email Correspondence Entered

Apr 11, 2018

Correspondence Received In Law Office

Apr 5, 2018

Assigned To Lie

Mar 22, 2018

Teas Response To Office Action Received

Dec 19, 2017

Teas Change Of Correspondence Received

Dec 14, 2017

Notification Of Non-Final Action E-Mailed

Dec 14, 2017

Non-Final Action E-Mailed

Dec 14, 2017

Non-Final Action Written

Dec 14, 2017

Assigned To Examiner

Sep 15, 2017

New Application Office Supplied Data Entered

Sep 14, 2017

New Application Entered